U.S. Physical Therapy Reports Strong Growth

U.S. Physical Therapy reported its earnings for the fourth quarter and full year ended December 31, 2023. In the fourth quarter of 2023, the company's revenue was $159.7 million, an increase of 12.5% compared to the same period in 2022. The net income for the fourth quarter was $10.8 million, which marks a 15.8% increase from the fourth quarter of 2022.

For the full year 2023, U.S. Physical Therapy reported revenue of $612.3 million, showing an increase of 10.6% from the previous year. The net income for the full year was $38.6 million, a 23.8% increase from the net income in the prior year.

The company's earnings before interest, taxes, depreciation, and amortization (EBITDA) for the fourth quarter of 2023 was $24.6 million, which is a 13.9% increase compared to the same period in 2022. For the full year 2023, the EBITDA was $96.2 million, representing a 12.5% increase from the previous year.

U.S. Physical Therapy's clinics experienced a 3.6% increase in same-store visits in the fourth quarter of 2023 compared to the fourth quarter of 2022. For the full year, the same-store visits increased by 3.2% compared to the prior year.

The company's cash flow from operations for the full year 2023 was $85.6 million, showing an increase of 14.1% compared to the previous year.

If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS